Searched for
ROCHE INDIA NEWS
Obesity drugs gain weight in labs: Several clinical trials by big and small pharma cos underwayDriven by the success of Wegovy and Mounjaro, numerous pharma companies are developing anti-obesity drugs, with over 170 in various stages....
Dr Reddy's Laboratories jumps into the fray for Biogen's biosimilarsDr Reddy's Laboratories (DRL) and Intas Pharmaceuticals, both Indian companies, are reportedly in the race to acquire the biosimilar produc...
Roche India arm leases 2 lakh sq ft office spaceRoche Information Solutions India, the healthcare digital entity of the global pharmaceutical major, will be paying rentals of over ₹210 cr...
Delta Plus: Key things to know about new coronavirus variantOne potential risk that has sparked unease among the medical community is that the new variant may be able to bypass immunity provided by b...
Amid Covid gloom, there is a good news for employeesFour out of five companies of 500 surveyed by Aon in May said they are not instituting across-the-board pay cuts. And nearly 70% said they ...
Lawsuits of big firms of telecom, pharma kept HC busy in 2017The decision consequently allowed pharma firms Biocon and Mylan to sell their version of Roche's drug for treating two kinds of breast canc...
Roche vs Indian Pharma: The battle for a cheaper cancer drugThe companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...
Roche begins probe into Avastin use for eye ailmentsRoche has initiated an internal investigation following reports the it had been used in certain eye ailments and damaged the vision of 15 p...
5 startups have a brilliant plan to tackle the multibillion-dollar fake drug scourgeCompanies have stepped in to help consumers authenticate the drugs themselves using mobile technology, including these start-ups.
New drug approves immunotherapy for Cancer treatmentMerck’s competitors have lined up their own immunotherapy drugs. They include Bristol Myers Squibb (BMS), Roche & Novartis & several smalle...
Little support for pharma MNCs on patent issueThe flexibilities are there and they have never been questioned by anyone in the WTO.
Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...
- Hotel industry on recovery path, room tariff goes up: Report
The hotel tariff went up by 12% in the first 6 months of this yr in the country amid rise in demand for hotel rooms from domestic traveller...
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning trade
Shares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Japan's Takeda eyes Lupin, Cipla pharma business
Takeda, Japan's largest pharmaceutical firm, has begun talks with two of India's biggest companies for purchasing either of their pharma bu...
- Hetero bags UAE deal for swine flu drug
The United Arab Emirates’ health ministry has given approval to Neopharma to manufacture a version of flu drug Tamiflu in a joint venture w...
- Private labs in price war for H1N1 testing
The health ministry is yet to give private labs the go-ahead to test samples for H1N1 swine flu but a price war has already begun among the...
- Ranbaxy recalls drug in US
Ranbaxy Laboratories is voluntarily recalling a batch of its best-selling anti-acne drug remaining in the US market that was banned earlier...
- Natco plans copy of Roche cancer drug
Some more good news could be around the corner for cancer patients and healthcare groups campaigning for access to cheaper medicines. A sec...
- Blogs provide window to pharmaceutical industry in India
Discussions are posted by bloggers on ayurveda, biogenerics, combination drugs, patents, HIV as well as individual pharma cos. Scripting In...